The global antibody purification service market size was valued at USD 2.89 billion in 2025 and is projected to grow from USD 3.10 billion in 2026 to USD 5.38 billion by 2034, registering a CAGR of 7.14% during the forecast period (2026–2034). North America dominated the antibody purification service market with a share of 42.78% in 2025.
Antibody purification services isolate antibodies from biological samples and cell cultures to obtain therapeutics antibodies with the required purity, concentration, and quality. They are tracked under SAC Code 998111 (research and experimental development services in natural sciences) and SIC Code 8731 (commercial physical and biological research).
The antibody purification service market demand is driven by the use of antibodies in research, diagnostics, and biopharmaceutical development, along with the need for high-purity antibody samples. Pharmaceutical biotechnology companies are outsourcing purification processes to specialized service providers, contributing to antibody purification service market growth.
By Type
By Antibody Type
By End User
Download a Free Sample To learn more about this report,
Molecule-Specific Alternatives to Protein A Purification
The antibody purification service market analysis shows a shift from standard Protein A workflows toward molecule-specific purification methods. Alternative affinity ligands and customized polishing steps are being used for bispecific antibodies, antibody fragments, and other complex antibody formats.
Continuous Chromatography-Based Purification Services
Continuous chromatography services are using antibody capture and purification services. Service providers are incorporating continuous processing to improve resin utilization, reduce processing time, and support scalable purification workflows.
Supply chain disruptions are expected to have a moderate impact on the antibody purification service market share, given its direct exposure to shortages of chromatography resins, laboratory reagents, and single-use components. The market is expected to experience a capacity-constrained recovery, as limited availability of specialized purification materials can restrict service capacity. The market is projected to grow at a CAGR of 7.14%, but supply chain constraints could reduce growth by 1.5 percentage points, resulting in a growth of around 5.64%. As supply conditions normalize, antibody purification service market growth is expected to gradually return to 7.14%.
The antibody purification service market forecasts strategic investment activity directed toward downstream processing and expression systems. In April 2026, Ferrosa Therapeutics raised USD 3.5 million in seed financing to advance its bispecific antibody program. The investment supports antibody development and engineering activities, including production and characterization workflows relevant to antibody service providers.
Need for High-Purity Antibodies for Therapeutic Applications and Outsourcing of Multistep Antibody Purification Processes
The use of antibodies in therapeutic development and specialized research creates a need for highly purified antibody preparations. Purification services can remove host-cell recombinant proteins, aggregates, nucleic acids, and other impurities that may affect antibody quality. This need is increasing the use of specialized purification workflows for research-grade and therapeutic antibody products.
The complexity of antibody purification encourages biotechnology companies and research organizations to outsource specialized processing activities. Service providers can perform multistep workflows such as protein A chromatography, ion-exchange chromatography, polishing, concentration, and buffer exchange using dedicated equipment. This model allows developers to access purification expertise without establishing complete in-house purification infrastructure.
Antibody-Specific Purification Variability and Recovery Losses Restrain Market Expansion
Differences in antibody structure, concentration, and impurities can require customized purification conditions for each project. These variations can make process standardization difficult and reduce the suitability of fixed purification workflows, which may limit service scalability.
Antibody purification can involve multiple filtration, chromatography, and buffer-exchange stages that may reduce product recovery. Higher recovery losses can lower the usable antibody yield from each batch, which may increase repeat processing requirements and restrict adoption for yield-sensitive projects.
Spatial Proteomics and Antibody Fragment Purification Create Opportunities for Market Players
Spatial proteomics creates a niche opportunity for antibody purification providers. Companies can purify antibodies used for tissue mapping and protein analysis. High-purity products can support reliable results in these specialized workflows.
Antibody fragment purification offers another specialized opportunity. Service providers can handle fragments such as single-chain variable fragments, antigen-binding fragments, and nanobodies. Dedicated purification services can help research companies work with these smaller antibody formats.
In 2025, affinity chromatography dominated the type segment with a share of 43.5% in 2025. This dominance is led by its high selectivity and widespread use for isolating antibodies from complex biological mixtures.
Hydrophobic Interaction Chromatography is expected to grow at a CAGR of 7.14 during the forecast period. This growth is driven by the demand for high-purity antibody purification, as HIC provides effective removal of aggregates, host-cell proteins, and other process-related impurities during downstream polishing.
Request Customizationto receive a tailored report.
Monoclonal antibodies held the largest share of 78.3% in 2025 in the antibody type segment. This reflects the extensive use of monoclonal antibodies in therapeutic development, diagnostics, and biopharmaceutical research.
The polyclonal antibodies segment is projected to undergo growth at a 5.82% CAGR during the forecast period. This growth is supported by the demand for multi-epitope antibody recognition in research, diagnostics, and therapeutic applications, supporting their use where broad target detection and high sensitivity are required.
Pharmaceutical companies represented 44.6% of the end user segment in 2025. This dominance is led by the adoption of antibody purification services across drug development and biopharmaceutical manufacturing activities.
Clinical Research Organizations (CRO) & Contract Development and Manufacturing Organizations (CDMOs) will expand to 8.18% CAGR during the forecast period. Outsourcing of antibody development, purification, and process-related activities to specialized service providers boost segment growth.
Speak to an Analystto discuss market opportunities.
The North America antibody purification service market accounted for a share of 39.2% in 2025.
National Institutes of Health (NIH) National Research Service Award and biomedical research funding ecosystem, which supports antibody-based research across immunology, oncology, infectious diseases, and therapeutic development. This research activity is strengthening demand for antibody purification services used to obtain high-purity antibodies for laboratory studies, assay development, and preclinical research.
Canadian Institutes of Health Research (CIHR) Project Grant program funds biomedical and health research involving areas such as immunology, cancer, and infectious diseases. This research activity is supporting demand for antibody purification and protein processing services required for antibody characterization, assay development, and translational research.
Unlock Regional Insightsto access country-level data, & regional trends.
The Asia Pacific antibody purification service market is likely to grow at a CAGR of 9.33% during the forecast period, making it the fastest-growing region.
National Natural Science Foundation of China (NSFC) supports research in immunology, molecular biology, oncology, and biotechnology. Rising investment in these fields is expanding antibody discovery, protein research, and laboratory testing activities across academic and pharmaceutical institutions.
Japan’s AMED (Japan Agency for Medical Research and Development) carry drug discovery and biomedical research, including the development of biologics and advanced therapeutic approaches. This is strengthening demand for high-quality research materials and downstream protein processing as antibody development programs expand.
India’s Department of Biotechnology (DBT) hold up biotechnology research and development through funding and commercialization programs for biologics and therapeutic innovations. The expanding biotechnology ecosystem is increasing research activity in antibody development, protein characterization, and preclinical testing.
The Europe antibody purification service is anticipated to record a growth rate of 6.83% during the forecast period.
Germany’s High-Tech Agenda Deutschland strengthens investment in biotechnology, life sciences, and advanced research infrastructure. This is supporting growth in antibody discovery, protein analysis, and laboratory-based biopharmaceutical research across universities and research institutions.
The UK’s Life Sciences Vision promotes innovation in medicines, biotechnology, and advanced research while strengthening collaboration between academia and industry. This encourages broader development of biologics and antibody-based research programs, increasing the need for reliable downstream laboratory processes.
The Latin America antibody purification service market is projected to reach a CAGR of 7.36% during the forecast period. Brazil’s National Fund for Scientific and Technological Development (FNDCT) supports research and innovation across biotechnology, health sciences, and pharmaceutical development. Mexico’s National Council of Humanities, Sciences and Technologies (CONAHCYT) supports scientific research and biotechnology development through research funding and institutional programs.
The Middle East & Africa antibody purification service market is estimated to register a growth rate of 7.58% during the forecast period. UAE's National Strategy for Innovation identifies biotechnology and advanced healthcare as priority areas for scientific and technological development. South Africa’s National Health Research Strategy 2021–2030 emphasizes strengthening health research capacity and supporting research in areas such as infectious diseases and biotechnology.
September 2026: Sartorius partnered with MAbSilico to launch an integrated service combining artificial intelligence-based protein assessment with automated, high-throughput cell line development for therapeutic antibody candidates.
March 2026: W. L. Gore & Associates introduced next-generation affinity membrane chromatography products with customized ligand partners to expand scalable purification solutions for antibody-based therapies.
June 2026: Lonza announced an expansion of its Visp manufacturing facility with additional purification and analytical capabilities.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Red Biotechnology Market Size, Share, Growth, Forecast, 2034
Cell Culture Market Size, Share, Growth, Analysis, Report, 2034
Cell Line Development Services Market Size, Share, 2034
Base Editing Market Size, Share, Growth, Analysis, Report, 2034
Metagenomic Sequencing Market Size, Share, Growth, Analysis, 2034
Gene Therapy Cell Culture Media Market Size, Share, Growth, 2034
We are featured on:
sales@straitsresearch.com